4[1]Finkielstein D,Schweitzer P.Role of angiotensin-converting enzyme inhibitors in the prevention of atrial fibrillation[J].Am J Cardiol,2004,93(6):734-736.
5[2]Pandozi C,Santini M.Update on atrial remodelling owing to rate:does atrial fibrillation always 'beget' atrial fibrillation?[J].Eur Heart J,2001,22(7):541-553.
6[3]Sanders P,Morton JB,Davidson NC,et al.Electrical remodeling of the atria in congestive heart failure:electrophysiological and electroanatomic mapping in humans[J].Circulation,2003,108(12):1461-1468.
7[4]Todd DM,Skanes AC,Guiraudon G,et al.Role of the posterior left atrium and pulmonary veins in human lone atrial fibrillation:electrophysiological and pathological data from patients undergoing atrial fibrillation surgery[J].Circulation,2003,108(25):3108-3114.
8[5]Kumagai K,Nakashima H,Urata H,et al.Effects of angiotensin Ⅱ type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation[J].J Am Coll Cardiol,2003,41(12):2197-2204.
9[6]Maggioni AP,Latini R,Carson PE,et al.Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:results from the Valsartan Heart Failure Trial (ValHeFT)[J].Am Heart J,2005,149(5):548-557.
10[7]Unger T.The role of the renin-angiotensin system in the development of cardiovascular disease[J].Am J Cardiol,2002,89(2A):3A-9A.
